DFDandong Fang

Dandong Fang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dandong Fang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Weiqin Li

    Department of Critical Care Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China

    2 shared publications
  • Haibin Hao

    Department of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang, China

    1 shared publication
  • Hongbin Deng

    School of Integrated Traditional Chinese and Western Medicine, Jiangsu Health Vocational College, Nanjing 211800, China

    1 shared publication
  • Jiemei Fan

    Department of Critical Care Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210000, China

    1 shared publication
  • Keke Wu

    Jinling Clinical Medical College, Nanjing Medical University, Nanjing, China

    1 shared publication
  • Qi Wang

    Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; Key Laboratory of Animal Feed and Nutrition of Zhejiang Province, Institute of Animal Nutrition and Feed Sciences, College of Animal Sciences, Zhejiang University, Hangzhou 310058, China

    1 shared publication

Latest Publications

  • Open Access

    Bacillus amyloliquefaciens SC06 Ameliorated Intestinal Mucosal Injury by Regulated Intestinal Stem Cells Proliferation and Differentiation via Activating Wnt/β-Catenin Signal Pathway in Clostridium perfringens-Challenged Mouse

    by Hongbin Deng, Si Cheng, Jiemei Fan, Haibin Hao, Dandong Fang, Weiqin Li, Qi Wang

    The objective of our study was to verify the intervention effect of Bacillus amyloliquefaciens SC06 on NE by constructing a C. perfringens-induced intestinal damage mouse model. A total of 40 mice were randomly assigned to four treatments: CON (basal diet), CP (basal diet + C. perfringens), SC06 + CP (basal diet + SC06 + C. perfringens) and SC06 (basal diet + SC06). Our findings indicated that SC06 supplementation was effective in maintaining the integrity of the intestinal barrier, enhancing the antioxidant capacity of the intestine, reducing the generation of an inflammatory response, and suppressing enterocyte apoptosis in the presence of C. perfringens. Furthermore, SC06 supplementation enhanced the prefoliation of intestinal stem cells (ISC) and prompted their differentiation into goblet cells and Paneth cells. Moreover, our findings indicate that SC06 promotes the proliferation of C. perfringens-induced jejunum organoids and the expression of genes and proteins associated with ISC differentiation and regeneration. The mechanism by which SC06 modulates ISCs has been validated, and the results align with those obtained in vivo. In conclusion, the findings demonstrated that SC06 stimulates the proliferation and differentiation of ISCs through the activation of the Wnt/β-catenin signaling pathway, thereby accelerating epithelial regeneration and repair.


  • Macrophages in Septic Cardiomyopathy: Heterogeneity, Function, and Therapy

    by Keke Wu, Yuliang Ma, Yuchen Wang, Rong Wei, Dandong Fang, Weiqin Li

    Sepsis is a life-threatening condition characterized by multiple organ dysfunction resulting from a dysregulated host immune response to infection. Septic cardiomyopathy (SCM), one of the most severe complications of sepsis, manifests as myocardial tissue injury and functional impairment and serves as a primary contributor to mortality in septic patients. Macrophages, pivotal innate immune cells in the heart, are classified into distinct subsets based on their developmental origins and microenvironmental cues. The dual roles of macrophage subsets, mediating both injury and protection, during the pathogenesis of SCM remain under active investigation. This review delineates the heterogeneity of macrophage subsets in sepsis and their cardiac implications, with a focus on elucidating the molecular mechanisms underlying macrophage-mediated cardiac injury (e.g., secretion of myocardial depressant substances, inflammatory responses, induction of mitochondrial dysfunction, mediation of ferroptosis) and protective processes (e.g., anti-inflammatory responses, phagocytic repair). These insights aim to provide a theoretical foundation for developing targeted immunomodulatory therapies and precise interventions directed at the cardiac immune microenvironment.